AstraZeneca

AstraZeneca, the Anglo Swedish pharma company, which developed the Covid-19 vaccine with the University of Oxford, is moving away from its non-profit model and for it. The drugmake

AstraZeneca’s first-quarter earnings doubled, with its Covid-19 vaccine generating $275 million in revenue. The pharma company’s revenue for the quarter rose 15 percent

Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions a

CEO of AstraZeneca, Pascal Soriot, recently stated that researchers are vehemently working to fish out the ‘winning formula’ to boost the Oxford COVID-19 vaccine. The C

Get upcoming M&A news and updates here at the nation’s fastest-growing CEO magazine, Industry Leaders.

The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes as planned, t

Britain’s departure from the EU has forced companies including AstraZeneca Plc, GlaxoSmithKline Plc and Merck & Co. to build stockpiles of their medicines in preparation for

Pharmaceutical behemoth Pfizer has reportedly been in talks for acquisition of Allergan, which could be touted as the biggest acquisition of the year. This acquisition will create

AstraZeneca PLC, the global pharmaceutical giant and the UK’s second biggest drug company, informed that it planned to restructure itself by introducing downsizing program and re